77 related articles for article (PubMed ID: 3748655)
1. Biosynthetic somatomedin C (SM-C/IGF-I) increases the length and weight of Snell dwarf mice.
van Buul-Offers S; Ueda I; Van den Brande JL
Pediatr Res; 1986 Sep; 20(9):825-7. PubMed ID: 3748655
[TBL] [Abstract][Full Text] [Related]
2. Biosynthetic human growth hormone: effects on growth of Snell dwarf mice.
van Buul-Offers S; Van den Brande JL
Horm Metab Res; 1985 Jan; 17(1):20-4. PubMed ID: 3967843
[TBL] [Abstract][Full Text] [Related]
3. Human insulin-like growth factor (IGF) binding protein-1 inhibits IGF-I-stimulated body growth but stimulates growth of the kidney in snell dwarf mice.
Van Buul-Offers SC; Van Kleffens M; Koster JG; Lindenbergh-Kortleve DJ; Gresnigt MG; Drop SL; Hoogerbrugge CM; Bloemen RJ; Koedam JA; Van Neck JW
Endocrinology; 2000 Apr; 141(4):1493-9. PubMed ID: 10746655
[TBL] [Abstract][Full Text] [Related]
4. Growth-stimulating effects of somatomedin-/insulin-like peptides in Snell dwarf mice.
van Buul-Offers S; Hoogerbrugge CM; Branger J; Feijlbrief M; Van den Brande JL
Horm Res; 1988; 29(5-6):229-36. PubMed ID: 3220460
[TBL] [Abstract][Full Text] [Related]
5. Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I.
Skottner A; Clark RG; Fryklund L; Robinson IC
Endocrinology; 1989 May; 124(5):2519-26. PubMed ID: 2707163
[TBL] [Abstract][Full Text] [Related]
6. Recombinant insulin-like growth factor-II inhibits the growth-stimulating effect of growth hormone on the liver of Snell dwarf mice.
van Buul-Offers SC; Reijnen-Gresnigt MG; Hoogerbrugge CM; Bloemen RJ; Kuper CF; Van den Brande JL
Endocrinology; 1994 Sep; 135(3):977-85. PubMed ID: 7520865
[TBL] [Abstract][Full Text] [Related]
7. Co-administration of IGF-binding protein-3 differentially inhibits the IGF-I-induced total body and organ growth of Snell dwarf mice.
van Buul-Offers S; Reijnen-Gresnigt R; Bloemen R; Hoogerbrugge C; Van den Brande JL
Prog Growth Factor Res; 1995; 6(2-4):377-83. PubMed ID: 8817681
[TBL] [Abstract][Full Text] [Related]
8. The effects of biosynthetic insulin-like growth factor-1 supplementation on somatic growth, maturation, and erythropoiesis on the neonatal rat.
Philipps AF; Persson B; Hall K; Lake M; Skottner A; Sanengen T; Sara VR
Pediatr Res; 1988 Mar; 23(3):298-305. PubMed ID: 3353177
[TBL] [Abstract][Full Text] [Related]
9. The effects of pituitary, thyroid, pancreatic and sexual hormones on body length and weight and organ weights of Snell dwarf mice.
van Buul-Offers S
Growth; 1984; 48(1):101-19. PubMed ID: 6724329
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone and insulin-like growth factor I treatment increase testicular luteinizing hormone receptors and steroidogenic responsiveness of growth hormone deficient dwarf mice.
Chatelain PG; Sanchez P; Saez JM
Endocrinology; 1991 Apr; 128(4):1857-62. PubMed ID: 2004605
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor I stimulates growth in normal growing rats.
Hizuka N; Takano K; Shizume K; Asakawa K; Miyakawa M; Tanaka I; Horikawa R
Eur J Pharmacol; 1986 Jun; 125(1):143-6. PubMed ID: 3732389
[TBL] [Abstract][Full Text] [Related]
12. Evidence for autocrine mitogenic stimulation by somatomedin-C/insulin-like growth factor I on an established human lung cancer cell line.
Minuto F; Del Monte P; Barreca A; Alama A; Cariola G; Giordano G
Cancer Res; 1988 Jul; 48(13):3716-9. PubMed ID: 3378214
[TBL] [Abstract][Full Text] [Related]
13. Effects of constant infusion with insulin-like growth factor-I (IGF-I) to immature female rats on body weight gain, tissue growth and sexual function. Evidence that such treatment does not affect sexual maturation of fertility.
Gruaz NM; d'Allèves V; Charnay Y; Skottner A; Ekvärn S; Fryklund L; Aubert ML
Endocrine; 1997 Feb; 6(1):11-9. PubMed ID: 9225110
[TBL] [Abstract][Full Text] [Related]
14. Early effects of streptozotocin-induced diabetes on insulin-like growth factor-I in the kidneys of growth hormone-transgenic and growth hormone-deficient dwarf mice.
Jacobs ML; Chandrashekar V; Bartke A; Weber RF
Exp Nephrol; 1997; 5(4):337-44. PubMed ID: 9259189
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone.
Merchav S; Tatarsky I; Hochberg Z
J Clin Invest; 1988 Mar; 81(3):791-7. PubMed ID: 2963830
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats.
Guler HP; Zapf J; Scheiwiller E; Froesch ER
Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4889-93. PubMed ID: 3387445
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone differentially inhibits thyroxine- or growth hormone-induced body and organ growth of Snell dwarf mice.
Rooman RP; Kuijpers G; Gresnigt R; Bloemen R; Koster JG; van Buul-Offers SC
Endocrinology; 2003 Jun; 144(6):2553-8. PubMed ID: 12746318
[TBL] [Abstract][Full Text] [Related]
18. The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats.
Frystyk J; Vinter-Jensen L; Skjaerbaek C; Flyvbjerg A
Growth Regul; 1996 Mar; 6(1):48-54. PubMed ID: 8717450
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone treatment increases transmural colonic growth in GH-deficient dwarf rats.
Tei TM; Kissmeyer-Nielsen P; Christensen H; Flyvbjerg A
Growth Horm IGF Res; 2000 Apr; 10(2):85-92. PubMed ID: 10931746
[TBL] [Abstract][Full Text] [Related]
20. Toxicology and carcinogenesis studies of 3,3',4,4'-tetrachloroazobenzene (TCAB) (CAS No. 14047-09-7) in Harlan Sprague-Dawley rats and B6C3F1 mice (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2010 Nov; (558):1-206. PubMed ID: 21383777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
